Paper42164352
DARS2 serves as an independent prognostic factor and participates in multiple biological processes in bladder urothelial carcinoma.
Qiu R and 8 others. Transl Androl Urol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. DARS2 serves as an independent prognostic factor and participates in multiple biological processes in bladder urothelial carcinoma. Papers, record 42164352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42164352
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- DARS2 serves as an independent prognostic factor and participates in multiple biological processes in bladder urothelial carcinoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37626419 | DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinoma. | J Transl Med | 2023 | https://conductscience.org/library/papers/37626419 | PubMed |
| 2 | 40294008 | Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations. | Cancer Discov | 2025 | https://conductscience.org/library/papers/40294008 | PubMed |
| 3 | 38299141 | Prognostic biomarker DARS2 correlated with immune infiltrates in bladder tumor. | Front Immunol | 2023 | https://conductscience.org/library/papers/38299141 | PubMed |
| 4 | 40185339 | Aminolevulinate/iron exposure elicited Nrf-2-mediated cytoprotection in DARS2 deficient fibroblasts with impaired energy and antioxidant metabolisms. | Biochim Biophys Acta Mol Basis Dis | 2025 | https://conductscience.org/library/papers/40185339 | PubMed |
| 5 | 33850871 | Development and validation of a prediction model for lung adenocarcinoma based on RNA-binding protein. | Ann Transl Med | 2021 | https://conductscience.org/library/papers/33850871 | PubMed |
| 6 | 40683603 | Restoration of N-glycosylation via leucine-activated leucyl-tRNA synthetase 1 overcomes chemoresistance in intrahepatic cholangiocarcinoma. | J Hepatol | 2026 | https://conductscience.org/library/papers/40683603 | PubMed |
| 7 | 40301173 | The tumor-promoting role of methionyl-tRNA synthetase 1 in ovarian cancer and its potential mechanisms. | Med Oncol | 2025 | https://conductscience.org/library/papers/40301173 | PubMed |
| 8 | 38582099 | Integrative Single Cell Atlas Revealed Intratumoral Heterogeneity Generation from an Adaptive Epigenetic Cell State in Human Bladder Urothelial Carcinoma. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38582099 | PubMed |
| 9 | 40754534 | Mitochondrial metabolism and cancer therapeutic innovation. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40754534 | PubMed |
| 10 | 41551149 | Prokaryotic organelle mitochondria drive tumorigenesis: "the original sin". | Front Oncol | 2025 | https://conductscience.org/library/papers/41551149 | PubMed |
| 11 | 40172969 | DDX54 downregulation enhances anti-PD1 therapy in immune-desert lung tumors with high tumor mutational burden. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40172969 | PubMed |
| 12 | 36937395 | Evaluation of mitochondrial biogenesis and ROS generation in high-grade serous ovarian cancer. | Front Oncol | 2023 | https://conductscience.org/library/papers/36937395 | PubMed |
| 13 | 38418280 | Mitochondrial dysfunction in lipid processing and gastrointestinal disorders. | Trends Endocrinol Metab | 2024 | https://conductscience.org/library/papers/38418280 | PubMed |
| 14 | 38382106 | Functional enrichment analysis reveals the involvement of DARS2 in multiple biological pathways and its potential as a therapeutic target in esophageal carcinoma. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/38382106 | PubMed |
| 15 | 40777041 | Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy. | Front Immunol | 2025 | https://conductscience.org/library/papers/40777041 | PubMed |
| 16 | 34239534 | Identification of the Functions and Prognostic Values of RNA Binding Proteins in Bladder Cancer. | Front Genet | 2021 | https://conductscience.org/library/papers/34239534 | PubMed |
| 17 | 41035672 | Identification of amino acid metabolism-related gene Leucyl-tRNA synthetase 1 (LARS1) as a potential prognostic and therapeutic target in hepatocellular carcinoma. | Front Oncol | 2025 | https://conductscience.org/library/papers/41035672 | PubMed |
| 18 | 41639505 | The role of Alanyl-tRNA synthetase 1 lactylation in tumors and other diseases. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41639505 | PubMed |
| 19 | 40485603 | Mechanistic Foundations of KRAS-Driven Tumor Ecosystems: Integrating Crosstalk among Immune, Metabolic, Microbial, and Stromal Microenvironment. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40485603 | PubMed |
| 20 | 40911595 | Restoring mitochondrial quantity and quality to reverse the Warburg effect and drive neuroblastoma differentiation. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40911595 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| DARS2 | 55157 | PubTator's text mining | https://conductscience.org/library/genes/55157 | NCBI Gene |
| RET | 5979 | PubTator's text mining | https://conductscience.org/library/genes/5979 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42164352
GET https://conductscience.org/api/papers/v1/42164352/references?page=2